Pre-clinical effects of metformin and aspirin on the cell lines of different breast cancer subtypes
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pre-clinical effects of metformin and aspirin on the cell lines of different breast cancer subtypes
Authors
Keywords
Breast cance, Drug repurposing, Metformin, Aspirin
Journal
INVESTIGATIONAL NEW DRUGS
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2018-02-02
DOI
10.1007/s10637-018-0568-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anticancer effect of acid ceramidase inhibitor ceranib-2 in human breast cancer cell lines MCF-7, MDA MB-231 by the activation of SAPK/JNK, p38 MAPK apoptotic pathways, inhibition of the Akt pathway, downregulation of ERα
- (2018) Helen S. Vethakanraj et al. ANTI-CANCER DRUGS
- Targeting AMPK, mTOR and β-Catenin by Combined Metformin and Aspirin Therapy in HCC: An Appraisal in Egyptian HCC Patients
- (2017) Doaa Ali Abdelmonsif et al. Molecular Diagnosis & Therapy
- Dioscin induces prostate cancer cell apoptosis through activation of estrogen receptor-β
- (2017) Xufeng Tao et al. Cell Death & Disease
- Aspirin regulation of c-myc and cyclinD1 proteins to overcome tamoxifen resistance in estrogen receptor-positive breast cancer cells
- (2017) Ran Cheng et al. Oncotarget
- Aspirin induces cell death by directly modulating mitochondrial voltage-dependent anion channel (VDAC)
- (2017) Debanjan Tewari et al. Scientific Reports
- Metformin reduces gastric cancer risk in patients with type 2 diabetes mellitus
- (2016) Chin-Hsiao Tseng Aging-US
- Identification of novel estrogen receptor (ER) agonists that have additional and complementary anti-cancer activities via ER-independent mechanism
- (2016) Taelim Kim et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- The effect of aspirin and nonsteroidal anti-inflammatory drug use after diagnosis on survival of oesophageal cancer patients
- (2016) Jente van Staalduinen et al. BRITISH JOURNAL OF CANCER
- Aspirin use and the incidence of breast, colon, ovarian, and pancreatic cancers in elderly women in the Iowa Women’s Health Study
- (2016) Lisa E. Vaughan et al. CANCER CAUSES & CONTROL
- Proteomic modulation in breast tumors after metformin exposure: results from a “window of opportunity” trial
- (2016) K. Kalinsky et al. Clinical & Translational Oncology
- SAnDReS a Computational Tool for Statistical Analysis of Docking Results and Development of Scoring Functions
- (2016) Mariana Morrone Xavier et al. COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING
- Is aspirin use associated with a decreased risk of ovarian cancer? A systematic review and meta-analysis of observational studies with dose-response analysis
- (2016) Dongyu Zhang et al. GYNECOLOGIC ONCOLOGY
- Protective effects of levamisole, acetylsalicylic acid, and α-tocopherol against dioxin toxicity measured as the expression of AhR and COX-2 in a chicken embryo model
- (2016) Kinga Gostomska-Pampuch et al. HISTOCHEMISTRY AND CELL BIOLOGY
- The phenomenon of acquired resistance to metformin in breast cancer cells: The interaction of growth pathways and estrogen receptor signaling
- (2016) Alexander M. Scherbakov et al. IUBMB LIFE
- Impact of metformin on metastases in patients with breast cancer and type 2 diabetes
- (2016) Louis Jacob et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Lipoxin A4Attenuates Cell Invasion by Inhibiting ROS/ERK/MMP Pathway in Pancreatic Cancer
- (2016) Liang Zong et al. Oxidative Medicine and Cellular Longevity
- Metformin induces apoptosis via a mitochondria-mediated pathway in human breast cancer cells in vitro
- (2016) ZHEN-YUAN GAO et al. Experimental and Therapeutic Medicine
- Combination of COX-2 expression and PIK3CA mutation as prognostic and predictive markers for celecoxib treatment in breast cancer
- (2016) Sandrine Tury et al. Oncotarget
- Aspirin and atenolol enhance metformin activity against breast cancer by targeting both neoplastic and microenvironment cells
- (2016) Giovanna Talarico et al. Scientific Reports
- Aspirin Breaks the Crosstalk between 3T3-L1 Adipocytes and 4T1 Breast Cancer Cells by Regulating Cytokine Production
- (2016) Chia-Chien Hsieh et al. PLoS One
- Aspirin in the Treatment of Cancer: Reductions in Metastatic Spread and in Mortality: A Systematic Review and Meta-Analyses of Published Studies
- (2016) Peter C. Elwood et al. PLoS One
- Metformin attenuated the inflammation after renal ischemia/reperfusion and suppressed apoptosis of renal tubular epithelial cell in rats
- (2015) Zhi-shun Wang et al. Acta Cirurgica Brasileira
- DEPTOR-related mTOR suppression is involved in metformin's anti-cancer action in human liver cancer cells
- (2015) Akio Obara et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Lifetime use of nonsteroidal anti-inflammatory drugs and breast cancer risk: results from a prospective study of women with a sister with breast cancer
- (2015) Sangmi Kim et al. BMC CANCER
- Increased COX-2 expression in epithelial and stromal cells of high mammographic density tissues and in a xenograft model of mammographic density
- (2015) G. L. Chew et al. BREAST CANCER RESEARCH AND TREATMENT
- Lipid mediator lipoxin A4 inhibits tumor growth by targeting IL-10-producing regulatory B (Breg) cells
- (2015) Zheng Wang et al. CANCER LETTERS
- Metformin affects the features of a human hepatocellular cell line (HepG2) by regulating macrophage polarization in a co-culture microenviroment
- (2015) Miaojiao Chen et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Metformin exerts anticancer effects through the inhibition of the Sonic hedgehog signaling pathway in breast cancer
- (2015) CONG FAN et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Aspirin blocks growth of breast tumor cells and tumor-initiating cells and induces reprogramming factors of mesenchymal to epithelial transition
- (2015) Gargi Maity et al. LABORATORY INVESTIGATION
- Lipoxins exert antiangiogenic and anti-inflammatory effects on Kaposi's sarcoma cells
- (2015) Alexandru Marginean et al. Translational Research
- Metformin inhibits the proliferation, metastasis, and cancer stem-like sphere formation in osteosarcoma MG63 cells in vitro
- (2015) Xu Chen et al. TUMOR BIOLOGY
- Aspirin inhibits lipopolysaccharide-induced COX-2 expression and PGE2production in porcine alveolar macrophages by modulating protein kinase C and protein tyrosine phosphatase activity
- (2014) Yuzhong Duan et al. BMB Reports
- Protective effects of n-6 fatty acids-enriched diet on intestinal ischaemia/reperfusion injury involve lipoxin A4and its receptor
- (2014) T Gobbetti et al. BRITISH JOURNAL OF PHARMACOLOGY
- The biguanides metformin and phenformin inhibit angiogenesis, local and metastatic growth of breast cancer by targeting both neoplastic and microenvironment cells
- (2014) Stefania Orecchioni et al. INTERNATIONAL JOURNAL OF CANCER
- Metformin reverses multidrug resistance in human hepatocellular carcinoma Bel-7402/5-fluorouracil cells
- (2014) SUNBIN LING et al. Molecular Medicine Reports
- Metformin in early breast cancer: a prospective window of opportunity neoadjuvant study
- (2012) Saroj Niraula et al. BREAST CANCER RESEARCH AND TREATMENT
- Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro
- (2011) Irina N. Alimova et al. CELL CYCLE
- Radiation resistance, invasiveness and metastasis are inflammatory events that could be suppressed by lipoxin A4
- (2011) Undurti N. Das PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- Lipoxin and Aspirin-Triggered Lipoxins
- (2011) Mario Romano TheScientificWorldJOURNAL
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
- (2009) Garrett M. Morris et al. JOURNAL OF COMPUTATIONAL CHEMISTRY
- Aspirin-triggered lipoxin induces CB1-dependent catalepsy in mice
- (2009) Fabrício A. Pamplona et al. NEUROSCIENCE LETTERS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started